Resistance profile of adefovir dipivoxil (ADV) in immunocompetent and immunocompromised chronic hepatitis B patients after 48 weeks of adefovir dipivoxil therapy
C.E. Westland; H. Yang; W.E. Delaney IV; V. Thibault; Y. Benhamou; C.S. Gibbs; M.D. Miller; M. Wulfsohn; M. Sullivan; J. Fry; C.L. Brosgart; S. Xiong
作者C.E. Westland; H. Yang; W.E. Delaney IV; V. Thibault; Y. Benhamou; C.S. Gibbs; M.D. Miller; M. Wulfsohn; M. Sullivan; J. Fry; C.L. Brosgart; S. Xiong